Real-time enrollment status for this ocular hyperemia clinical trial
Current Status
Recruiting
Checked: October 16, 2026 at 10:31 PM UTC
| NCT Number | NCT07578363 |
| Recruiting Status | Recruiting |
| Condition | Ocular Hyperemia |
| Phase | PHASE3 |
| Target Enrollment | 178 participants |
| Active Locations | 5 sites in the US |
| Sponsor | Alcon Research |
| Last Updated on CT.gov | October 16, 2026 (22 hours ago) |
As of October 16, 2026: Clinical trial NCT07578363 is currently recruiting participants. This phase3 study for ocular hyperemia is actively seeking new participants at 5 locations across the United States. The study is sponsored by Alcon Research. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07578363 is actively recruiting participants as of October 16, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 5 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07578363 was last updated 22 hours ago (October 16, 2026). HelloStudys verifies this status automatically.